Nanoplatform strategy for multimodal cancer therapy and tumor visualization

Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease’s intricate and varied nature.

Opinion | Bring Environmental Sustainability to Your Practice in 2025

Sack is an associate clinical professor, a gastroenterologist, and executive director and editor of My Green Doctor. Healthcare practices have a significant environmental impact, and

February 13, 2025

CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK – Biotech Investments

Issuer: CureVac / Key word(s): Study results 01.11.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Solid

November 2, 2023

The NASH market holds untapped potential – Pharmaceutical Technology

Source: GlobalData, Deals Database (Accessed: 26 July 2023) © GlobalData. Note: Percentages were calculated from the total number of deals that occurred in 2018–2022. The

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.